title: AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association.
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: S S
authors.initials: SS
authors.lastname: Anand
authors.forename: J L
authors.initials: JL
authors.lastname: Halperin
authors.forename: V
authors.initials: V
authors.lastname: Fuster
mesh_terms: D000789:Angina, Unstable / Q000517:prevention & control; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008954:Models, Biological; D009203:Myocardial Infarction / Q000517:prevention & control; D013921:Thrombocytopenia / Q000139:chemically induced; D013927:Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D014481:United States
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin